FDA Postdoctoral Research Fellowship in Workflow Assessment
- Oak Ridge Institute for Science and Education
- Location: Silver Spring, MD
- Job Number: 7069772
- Posting Date: Sep 14, 2020
Job Description*Applications will be reviewed on a rolling-basis.
A postdoctoral research opportunity is currently available with the U.S. Food and Drug Administration (FDA), Center for Devices and Radiological Health (CDRH), Office of Science and Engineering Laboratories (OSEL), Division of Imaging, Diagnostics, and Software Reliability (DIDSR), located in Silver Spring, Maryland.
Under the guidance of a mentor, the selected participant will be involved in the evaluation of prioritization, triage, and rule-out systems for radiology workflow. Such systems use artificial intelligence algorithms to detect abnormalities from radiological images and triage radiology workflow. The research project aims to establish methods to assess different prioritization and triage policies and diagnostic performance under various clinical environments.
Anticipated Appointment Start Date: September 2020
This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was established through an interagency agreement between DOE and FDA. The initial appointment is for one year, but may be renewed upon recommendation of FDA contingent on the availability of funds. The participant will receive a monthly stipend commensurate with educational level and experience. Proof of health insurance is required for participation in this program. The appointment is full-time at FDA in the Silver Spring, Maryland, area. Participants do not become employees of FDA, DOE or the program administrator, and there are no employment-related benefits.
Completion of a successful background investigation by the Office of Personnel Management is required for an applicant to be on-boarded at FDA. OPM can complete a background investigation only for individuals, including non-US Citizens, who have resided in the US for a total of three of the past five years.
FDA requires ORISE participants to read and sign their FDA Education and Training Agreement within 30 days of his/her start date, setting forth the conditions and expectations for his/her educational appointment at the agency. This agreement covers such topics as the following:
Non-employee nature of the ORISE appointment;
Prohibition on ORISE Fellows performing inherently governmental functions;
Obligation of ORISE Fellows to convey all necessary rights to the FDA regarding intellectual property conceived or first reduced to practice during their fellowship;
The fact that research materials and laboratory notebooks are the property of the FDA;
ORISE fellow’s obligation to protect and not to further disclose or use non-public information.